Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation
INTERNATIONAL JOURNAL OF OBESITY, cilt.31, sa.7, ss.1119-1125, 2007 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 31 Sayı: 7
- Basım Tarihi: 2007
- Doi Numarası: 10.1038/sj.ijo.0803552
- Dergi Adı: INTERNATIONAL JOURNAL OF OBESITY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.1119-1125
- Anahtar Kelimeler: apolipoprotein B, central obesity, diabetes mellitus, dyslipidemia, hypertension, metabolic syndrome, DENSITY-LIPOPROTEIN CHOLESTEROL, CARDIOVASCULAR RISK-FACTORS, INSULIN-RESISTANCE, A-I, MYOCARDIAL-INFARCTION, ASSOCIATION, POPULATION, GLUCOSE, INDEXES
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet
Özet
Objectives: To investigate the role of serum apolipoprotein (apo) B levels in predicting metabolic syndrome (MS), hypertension, atherogenic dyslipidemia and type II diabetes.